Abiopharma

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001193125-26-349119 <b>Size:</b> 1 MB

New Form 8-K/A - DNA X, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001493152-26-037733 <b>Size:</b> 226 KB <br />Item 3.02: Unregistered Sales of Equity Securities <br />Item 8.01: Other Events

New Form 497AD - Eagle Point Credit Co <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001104659-26-095879 <b>Size:</b> 635 KB

New Form SCHEDULE 13G - Cambridge Acquisition Corp. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001193125-26-349116 <b>Size:</b> 8 KB

New Form SCHEDULE 13G - QuasarEdge Acquisition Corp <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001950677-26-000014 <b>Size:</b> 8 KB

New Form SCHEDULE 13G/A - Pono Capital Four, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001950677-26-000015 <b>Size:</b> 8 KB

New Form SCHEDULE 13G/A - APEX Tech Acquisition Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001950677-26-000018 <b>Size:</b> 8 KB

New Form SCHEDULE 13G/A - Future Money Acquisition Corp <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001950677-26-000019 <b>Size:</b> 8 KB

New Form SCHEDULE 13G - Lionheart Holdings <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001950677-26-000013 <b>Size:</b> 8 KB

New Form SCHEDULE 13G/A - XWELL, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000930413-26-002506 <b>Size:</b> 13 KB

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001839882-26-039883 <b>Size:</b> 289 KB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023723 <b>Size:</b> 338 KB

New Form S-8 - Cellyan Biotechnology Co., Ltd <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-089057 <b>Size:</b> 326 KB

The Marzetti Company to Webcast Fourth Quarter and Fiscal Year 2026 Conference Call

Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers